Press release
Asia-Pacific Inflammatory Bowel Disease Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025
Asia-Pacific Inflammatory Bowel Disease Market
Request a Free Sample of our Report on Asia-Pacific Inflammatory Bowel Disease Market: https://www.omrglobal.com/request-sample/asia-pacific-ibd-inflammatory-bowel-disease-market
Rapid urbanization and changing eating habits are also supposed to grow the market substantially in the region. Japan contributes considerably in the IBD market due to growing awareness regarding IBD and the established healthcare industry. Along with these economies, Australia, Indonesia, and Thailand are other major countries with advanced healthcare facilities and projected to show a significant growth rate during the forecasted period.
Asia-Pacific IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Asia-Pacific IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays.
Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.
A Full Report of Asia-Pacific Inflammatory Bowel Disease Market is Available at https://www.omrglobal.com/industry-reports/asia-pacific-ibd-inflammatory-bowel-disease-market
Asia-Pacific IBD Market Segmentation
By Disease Type
o Ulcerative Colitis
o Crohn's Disease
By Diagnostics
o Blood and Stool Tests
o Endoscopies,
o Ultrasound
o X-Ray
By Therapeutics
o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others
Regional Analysis
o China
o India
o Japan
o Rest of Asia-Pacific
Company Profiles
o AbbVie Inc.
o Allergan, PLC
o Boehringer Ingelheim International GmbH
o Daiichi Sankyo Co. Ltd.
o Eli Lilly and Co.
o Johnson & Johnson Services Inc.
o Mercator Pharmaceutical Solutions
o Pfizer Inc.
o RPG Life Sciences Ltd.
o Sanofi S.A.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-ibd-inflammatory-bowel-disease-market
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Inflammatory Bowel Disease Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025 here
News-ID: 1964756 • Views: …
More Releases from Orion Market Research
Diving Suits Market is Dazzling Worldwide and Forecast to 2031
The global diving suits market is estimated to record a CAGR of 4.5% during the forecast period. The need to grow the market for outdoor-inspired apparel and other related equipment has been recognized by the industry with new initiatives unfolding on a regular basis aimed at stimulating consumer interest, particularly in the young population. The marine industry is witnessing an increasing appeal of technologically advanced features, such as joystick docking control, automatic…
Automotive Paints Market Update Report 2024| Industry Trends, Demand, Leading Co …
Automotive paints market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period. The production of cost-effective and eco-friendly automotive paints in the market by players is expected to provide lucrative growth in the market over the forecast. Eco-friendly paints enable players to make a positive impact on the environment. Moreover, eco-friendly paints are long-lasting, and Facilities maintenance reduces costs while using eco-friendly paints. For instance,…
Air Duct Market is Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
Air Duct Market pipes which are utilized to convey air across the building. Air Duct Market research report reveals important insights into market scenario to enable key players in taking calculated decision making. Basically, one of the major purposes of market research reports is to maximize the business growth opportunities. It also helps key players to turn business into a successful business by increasing the profit level. The overall business…
Air Duct Cleaning Chemicals Market Is Expected to Exhibit Significant Growth Ove …
Global air duct cleaning chemicals market is anticipated to grow at a moderate CAGR of 3.1% during the forecast period (2024-2031). The duct cleaners are chemical solutions designed to clean ducts, including surfactants, solvents, and other agents. The increased focus of public and private organizations on R&D to find new application areas of these chemicals driving the global market growth. Some recent advancements in the global market include:
· …
More Releases for IBD
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,…
